NIFTY24,173.050.84%
SENSEX77,664.001.09%
BANKNIFTY56,305.001.43%
NIFTY IT30,124.301.22%
PHARMA22,986.352.36%
AUTO25,828.102.35%
FMCG51,140.500.11%
METAL12,786.250.82%
REALTY788.651.83%
ENERGY39,996.750.25%
NIFTY24,173.050.84%
SENSEX77,664.001.09%
BANKNIFTY56,305.001.43%
NIFTY IT30,124.301.22%
PHARMA22,986.352.36%
AUTO25,828.102.35%
FMCG51,140.500.11%
METAL12,786.250.82%
REALTY788.651.83%
ENERGY39,996.750.25%

Balrampur Chini Mills Ltd to Invest Rs 160 Crore in Lactogypsum Processing Plant

Balrampur Chini Mills Ltd, one of the largest integrated sugar companies in India, has announced plans to invest Rs 160 crore in setting up a lactogypsum processing plant in Uttar Pradesh. The company has also decided to raise up to Rs 450 crore through the issue of preferential shares to promoters as well as investors.

The proposed lactogypsum processing plant, which will be established at Kumbhi in Uttar Pradesh, is expected to have an installed capacity of about 76 lakh gypsum boards per annum. The plant will process lactogypsum generated as a byproduct from the company's poly lactic acid (PLA) manufacturing operations.

In a regulatory filing, the company stated that the board has approved the establishment of the lactogypsum processing plant at an estimated project cost of up to Rs 160 crore. The board also approved the utilisation of a portion of net proceeds from the preferential issue, amounting to up to Rs 160 crore, towards funding of the project.

Read also: Microsoft to Offer Buyout Option to Approximately 7% of US Workforce: Report Suggests

ProjectOriginal Estimated CostRevised Estimated CostIncrease
PLA Manufacturing PlantRs 2,850 croreRs 3,080 croreRs 230 crore
PLA Manufacturing Plant(approximately 8% increase)

The board also approved the upward revision of the estimated capital outlay of the PLA project from Rs 2,850 crore to Rs 3,080 crore. This revision is necessitated due to cost escalations of about Rs 230 crore, primarily on account of increase in prices of key construction materials, global supply chain disruptions, and to incorporate further changes in engineering/designing during modelling review.

The revised enhanced capex, including cost escalations, will be funded through issue of equity shares on a preferential basis, debt, and internal accruals, the company said. Furthermore, the board approved issuance and allotment of up to 93,16,771 equity shares for cash for Rs 483 apiece for an amount aggregating up to Rs 450 crore to promoters, members of the promoter group, and investors on a preferential basis.

In addition, the board gave the nod to raise up to Rs 200 crore through the issuance of non-convertible debentures (NCDs) on a private placement basis. Balrampur Chini Mills Ltd has ten sugar factories in UP with an aggregate sugarcane crushing capacity of 80,000 tonnes per day. The company also has distillery and co-generation operations of 1,050 kilo litre per day and 175.7 MW, respectively.

Read also: 63SATS Forms Partnership with PDA to Develop Cyber Defense Platform

As part of its diversification efforts, Balrampur Chini has ventured into the bio-plastic business and is setting up a PLA manufacturing plant at Kumbhi in UP with a total annual capacity of 80,000 tonnes.

Investor Takeaway

Investors should be aware of the company's expansion plans and potential growth opportunities.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.